Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 ,inter alia, to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, February 6, 2024, inter alia, to consider and approve unaudited Financial Results for the quarter ended December 31, 2023 and to consider declaration of dividend (if any).